Literature DB >> 15531904

Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver.

A Turchin1, D A Wiebe, E W Seely, T Graham, W Longo, R Soiffer.   

Abstract

We describe a series of cases of extreme hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver after an allogeneic bone marrow transplant. All of the patients presented with a total cholesterol in excess of 1000 mg/dl (25.9 mmol/l). At the time they were also noted to have pseudohyponatremia. Cholesterol appeared to be predominantly carried by lipoprotein X. Intrahepatic cholestasis leading to reflux of bile lipoproteins into the bloodstream and subsequent formation of protein X appears to be the mechanism underlying this phenomenon. Complications, including retinal cholesterol thromboembolism and cholesteroloma of the lung have been seen in the patient with the highest cholesterol levels. Severe hypercholesterolemia is an important, and likely more common than previously reported, long-term complication of allogeneic hematopoietic stem cell transplantation. It is important for clinicians to familiarize themselves with the diagnostic and therapeutic challenges this condition presents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15531904     DOI: 10.1038/sj.bmt.1704739

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  10 in total

1.  Severe hypercholesterolemia associated with decreased hepatic triglyceride lipase activity and pseudohyponatremia in patients after allogeneic stem cell transplantation.

Authors:  Yoshihiro Inamoto; Tamio Teramoto; Koji Shirai; Hideko Tsukamoto; Takaomi Sanda; Koichi Miyamura; Ikuo Yamamori; Noriyuki Hirabayashi; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

Review 2.  Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients.

Authors:  Bernard Lawrence Marini; Sung Won Choi; Craig Alan Byersdorfer; Simon Cronin; David G Frame
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-20       Impact factor: 5.742

3.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.

Authors:  Saro H Armenian; Wassim Chemaitilly; Marcus Chen; Eric J Chow; Christine N Duncan; Lee W Jones; Michael A Pulsipher; Alan T Remaley; Alicia Rovo; Nina Salooja; Minoo Battiwalla
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-30       Impact factor: 5.742

4.  When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson.

Authors:  Lisa P M Huygen; Jan Westerink; Gerben C Mol; Remy H H Bemelmans
Journal:  JACC Case Rep       Date:  2022-06-01

5.  Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis.

Authors:  Eric J Brandt; Shane M Regnier; Edward Ky Leung; Sharon H Chou; Beverly W Baron; Helen S Te; Michael H Davidson; Robert M Sargis
Journal:  Clin Lipidol       Date:  2015-08-01

6.  Detection of Lipoprotein X (LpX): A challenge in patients with severe hypercholesterolaemia.

Authors:  Agnieszka Ćwiklińska; Agnieszka Mickiewicz; Robert Kowalski; Barbara Kortas-Stempak; Agnieszka Kuchta; Krzysztof Mucha; Michał Makowiecki; Anna Gliwińska; Krzysztof Lewandowski; Leszek Pączek; Marcin Fijałkowski; Marcin Gruchała; Maciej Jankowski
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

7.  Hypercholesterolemia Due to Lipoprotein X: Case Report and Thematic Review.

Authors:  Laura Kattah; Andrés Gómez; Sebastián Gutiérrez; Kathalina Puerto; Eiman D Moreno-Pallares; Andrés Jaramillo; Carlos O Mendivil
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-09-29

8.  Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis.

Authors:  Rossella Colantuono; Chiara Pavanello; Andrea Pietrobattista; Marta Turri; Paola Francalanci; Marco Spada; Pietro Vajro; Laura Calabresi; Claudia Mandato
Journal:  Front Pediatr       Date:  2022-08-04       Impact factor: 3.569

9.  A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X.

Authors:  Edward B Neufeld; Lita A Freeman; Vinay Durbhakula; Maureen L Sampson; Robert D Shamburek; Sotirios K Karathanasis; Alan T Remaley
Journal:  Biology (Basel)       Date:  2022-08-22

10.  LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.

Authors:  Marcelo J A Amar; Lita A Freeman; Takafumi Nishida; Maureen L Sampson; Milton Pryor; Boris L Vaisman; Edward B Neufeld; Sotirios K Karathanasis; Alan T Remaley
Journal:  Pharmacol Res Perspect       Date:  2019-12-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.